Current Challenges in the Treatment of Relapsed/Refractory Malignant Haematological Conditions
23 September 2021
|
Event Name: |
ACTRIS Cell Therapy Lecture Series: Current Challenges in the Treatment of Relapsed/Refractory Malignant Haematological Conditions |
|
Date: |
23 Sep 2021 |
|
Time: |
12 to 1pm |
|
Synopsis: |
Haematologic malignancies are cancers that affect the blood, bone marrow, and lymph nodes. This classification includes both acute and chronic leukaemia as well as myeloma and lymphoma (Hodgkin’s and non-Hodgkin’s). Despite the varied clinical presentations, what these malignancies have in common are the propensity to relapse, and disease heterogeneity which leads to difficulties in disease control at the time of relapse.
Join this webinar to review the management of patients with relapsed/refractory malignancies and look at the growing role of precision and personalised medicine in the management of these patients. With a focus on the Singapore context, the talk aims to highlight the current challenges faced and how these have been addressed to optimise care for patients. |
|
Speaker: |
Dr Michelle Poon Senior Consultant Dept of Haematology-Oncology National University Cancer Institute |
GO BACK